EP Patent

EP3143997A2 — Methods of administering pirfenidone therapy

Assigned to Intermune Inc · Expires 2017-03-22 · 9y expired

What this patent protects

The disclosure relates to improved methods of administering pirfenidone therapy when ciprofloxacin is administered concomitantly.

USPTO Abstract

The disclosure relates to improved methods of administering pirfenidone therapy when ciprofloxacin is administered concomitantly.

Drugs covered by this patent

Patent Metadata

Patent number: EP3143997A2
Jurisdiction: EP
Classification: —
Expires: 2017-03-22
Drug substance claim: No
Drug product claim: No
Assignee: Intermune Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.